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Introduction
Caesarean section is the most common surgical  
procedure performed on women worldwide and  
infections following caesarean section occur in 
approximately 10% of Australian women. 
It is a special procedure because:
• There is a large and increasing volume performed globally
• Two people – mother and baby – are affected by surgery
•  The same surgery is often repeated at the same site
•  The surgical site is connected to a host of naturally 
occurring organisms – the vagina
Consequently there are unique risk factors for post-caesarean 
surgical site infection and endometritis (infection of the 
uterus). A selection of modifiable risk factors are summarised 
in Figure 1. These risk factors present opportunities to change 
infection control practice. However, there is inconsistent 
information across clinical guidelines regarding the most 
effective strategies for change and their associated costs. It 
is important to understand the most efficient way to prevent 
infection given scarce resources in the health system.
This PhD will evaluate the incremental cost-effectiveness  
of different interventions to prevent surgical site infection 
and endometritis following caesarean section in Australia. 
The research will also identify if cost-effectiveness varies by 
sub-groups such as hospital geographic region or patient  
risk status.
Methods
The health and cost consequences of changing from 
current practice to two alternative strategies will be 
evaluated through a cost-effectiveness analysis. A 
systematic review of surgical, infection prevention, 
obstetrics and midwifery literature will be conducted to 
identify the effective and relevant strategies for preventing 
post-caesarean infection. A bundle of the best clinical 
infection prevention strategies will be selected from the 
list identified. This hypothetical gold standard bundle 
will be the first alternative to current practice. The gold 
standard bundle will also be combined with a strategy to 
minimise weight increases during pregnancy for obese 
women as the second alternative to current practice.
A decision analytic Markov model will be built to represent 
the major health states that a woman enters following 
a caesarean section. When the model is finalised, cost-
effectiveness analysis will be run, based on a simulated 
cohort of at least 10 000 patients and reported as an 
incremental cost-effectiveness ratio (ICER) for each 
intervention (see Figure 2).
Different scenarios will be tested to see if they affect 
the cost-effectiveness results. Scenarios will include 
maintaining current practice but reducing the number of 
caesarean deliveries on maternal request and conducting 
the cost-effectiveness analysis with data from rural and 
remote hospitals only.
Expected Results
Modelling the health and cost consequences of the 
alternative strategies through a cost-effectiveness analysis 
will identify the efficient level of investment in infection 
control programmes that reduce surgical site infection and 
endometritis following caesarean section.  
Conclusions
A lack of good quality economic information is a major  
barrier to the health system using resources wisely.   
There is a dearth of information about the changes to cost 
and health outcomes from adopting new infection control 
practices to prevent post-caesarean infection.  This cost-
effectiveness study will inform health departments,  
hospitals and obstetricians about which infection control 
strategies give the most health gain for every dollar spent.
‘Real World’ Implications
Decisions about how much of the health budget  
should be allocated to preventing post-caesarean  
infection can be informed by cost-effectivness analysis.  
Implementing strategies that prevent the most infections 
for every dollar spent, might result in fewer maternal 
readmissions to hospital. 
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